These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 5563475
1. [Clinical effect of doberol. Significance for diagnosis and therapy]. Hähnel J. Med Welt; 1971 Mar 27; 13():512-6. PubMed ID: 5563475 [No Abstract] [Full Text] [Related]
2. [The beta-blocking drugs in hyperthyroidism. I. Effects on the cardiovascular syndrome]. Ghidini O, Bellotti G, De Gregori ME, Salazzari G, Giardina F. Minerva Med; 1971 Mar 31; 62(26):1363-73. PubMed ID: 4396565 [No Abstract] [Full Text] [Related]
3. [Effect of beta-receptor-blocking agents on physical working capacity and muscular blood circulation in hyperkinetic dysfunction of the blood circulation]. Kaltenbach M, Becker HJ, Brunn V. Verh Dtsch Ges Inn Med; 1968 Mar 31; 74():565-9. PubMed ID: 5714382 [No Abstract] [Full Text] [Related]
4. [Changes in pulse, blood pressure, heart size and ECG following administration of practolol (ICI 50172)]. Frisch P. Med Klin; 1971 Sep 24; 66(39):1303-8. PubMed ID: 5117317 [No Abstract] [Full Text] [Related]
5. The influence of sympathicolytics of the electrocardiogram. van Buchem FS, Bosschieter E. Proc K Ned Akad Wet C; 1970 Sep 24; 73(1):1-14. PubMed ID: 4392160 [No Abstract] [Full Text] [Related]
6. Hemodynamic effects of propranolol (Inderal) and H 56-28 (Aptin) in patients with acute myocardial infarction. A comparative study. Lund-Larsen G, Sivertssen E. Acta Med Scand; 1969 Sep 24; 186(3):187-91. PubMed ID: 5363494 [No Abstract] [Full Text] [Related]
7. Relative potency of intravenous prinodolol and propranolol in man. Arbab AG, Hicks DC, Turner P. Br J Pharmacol; 1971 Aug 24; 42(4):665P-666P. PubMed ID: 4940273 [No Abstract] [Full Text] [Related]
8. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal]. Bürgin D. Schweiz Med Wochenschr; 1968 Jun 22; 98(25):940-5. PubMed ID: 5699197 [No Abstract] [Full Text] [Related]
9. [Data on the effects of butydrine in patients with coronary insufficiency]. De Maestri C, Rinaldi AR. Minerva Cardioangiol; 1969 Feb 22; 17(2):142-50. PubMed ID: 5777638 [No Abstract] [Full Text] [Related]
14. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients. Piva M, Ongari R. Arzneimittelforschung; 1968 Feb 27; 18(2):179-88. PubMed ID: 5695376 [No Abstract] [Full Text] [Related]
16. [Clinical-pharmacological studies with a new beta receptor blocking substance (LB 46, Visken)]. Judmaier G, Dienstl F, Schwingshackl H, Amor H. Wien Klin Wochenschr; 1970 Dec 11; 82(50):891-3. PubMed ID: 5491146 [No Abstract] [Full Text] [Related]
17. [Cardiovascular dynamic effect of chorionic gonadotropin (clinical and instrumental findings)]. Melloni G, Fassini G. G Gerontol; 1971 Dec 11; 19(12):1003-38. PubMed ID: 5147500 [No Abstract] [Full Text] [Related]
18. [Clinical study on the action of a beta blocking agent (LB 46) on some manifestations of hyperthyroidism and hypothyroidism]. Bricaire H, Pandos. Presse Med (1893); 1971 Nov 27; 79(51):2301-4. PubMed ID: 5129469 [No Abstract] [Full Text] [Related]
19. [The effect of beta-receptor blockers and cardiac glycosides on the heart rate, systolic blood pressure and ST interval in submaximal ergometer exertion]. Schaller K, Lange S. Z Gesamte Inn Med; 1982 Jan 15; 37(2):50-3. PubMed ID: 7080551 [Abstract] [Full Text] [Related]